Portage Biotech, Inc. is a pharmaceutical company that identifies, finances, and develops best-in-class or first-in-class early-to-mid stage products. Portage chooses products with established scientific rationales and either creates management teams to develop these assets or augments a company’s existing management teams. Portage creates much of its value by developing pre-proof of concept assets through proof of concept (POC). Big Pharma is generally interested in acquiring or licensing assets only after POC.
100MM - 500MM
47 Avenue Road
Toronto, Ontario M5R 2G3
Send Message to Request Information
Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.
Stock Market Data
Market Data copyright © 2017 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by